[ad_1]
CORONAVIRUS NEWS
merciyes university (ERÜ) Center for Research and Development of Vaccines (ERAGEM) developed against the new type of coronavirus (Kovid-19) VaccineSecond phase dosing studies are reported to have been completed.
ERÜ Rector Prof. Dr. Mustafa Çalış, in his statement on his social media account, said: “The second phase 1 dosage of our local vaccine, which was developed by our university against Kovid-19 and supported by the Ministry of Health , it was completed today. No serious side effects observed. If all goes well, I wait until the end of this month. We are planning to move to 2. “He used the expressions.
In the local vaccine studies conducted at ERAGEM, the first dose was given to volunteers on November 5 and the second dose on November 26 within the scope of phase 1.
News presented to subscribers through the AA News Flow System (HAS) is published on the Anadolu Agency website in summary form. Get in touch to subscribe.
[ad_2]
